RIDGE PHARMA LIMITED

Company number 10612687

Date	Type	Description	View / Download
30 Mar 2020	TM01	Termination of appointment of Christian Alexander Rigg as a director on 31 December 2019	(1 page)
29 Nov 2019	CS01	Confirmation statement made on 29 November 2019 with no updates	(3 pages)
08 Jul 2019	AP01	Appointment of Mr Michael Denis Barker as a director on 1 July 2019	(2 pages)
23 May 2019	AA	Micro company accounts made up to 31 December 2018	(2 pages) Download iXBRL
30 Nov 2018	CS01	Confirmation statement made on 30 November 2018 with updates	(6 pages)
30 Nov 2018	PSC02	Notification of Nvm Private Equity Llp as a person with significant control on 4 September 2018	(2 pages)
19 Nov 2018	PSC07	Cessation of Harry Thomas Stratford as a person with significant control on 8 August 2018	(1 page)
19 Nov 2018	PSC07	Cessation of Caroline Stratford as a person with significant control on 8 August 2018	(1 page)
19 Nov 2018	PSC01	Notification of Caroline Stratford as a person with significant control on 23 July 2018	(2 pages)
19 Nov 2018	PSC01	Notification of Harry Thomas Stratford as a person with significant control on 23 July 2018	(2 pages)
19 Nov 2018	PSC09	Withdrawal of a person with significant control statement on 19 November 2018	(2 pages)
08 Nov 2018	AP01	Appointment of Mr Aaron Anthony Lawson-Clark as a director on 31 October 2018	(2 pages)
08 Nov 2018	TM01	Termination of appointment of Timothy Roland Levett as a director on 31 October 2018	(1 page)
04 Oct 2018	AP01	Appointment of Mr Timothy Roland Levett as a director on 4 September 2018	(2 pages)
04 Oct 2018	AP01	Appointment of Mr Christian Alexander Rigg as a director on 4 September 2018	(2 pages)
04 Oct 2018	TM01	Termination of appointment of Emma Louise Mcdonagh as a director on 4 September 2018	(1 page)
18 Sep 2018	SH10	Particulars of variation of rights attached to shares	(2 pages)
18 Sep 2018	SH08	Change of share class name or designation	(2 pages)
18 Sep 2018	SH01	Statement of capital following an allotment of shares on 4 September 2018 GBP 1,858.68	(4 pages)
18 Sep 2018	RESOLUTIONS	Resolutions RES12 ‐ Resolution of varying share rights or name RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(57 pages)
05 Sep 2018	RESOLUTIONS	Resolutions RES13 ‐ Auth to allot 08/08/2018 RES11 ‐ Resolution of removal of pre-emption rights	(1 page)
04 Sep 2018	SH01	Statement of capital following an allotment of shares on 8 August 2018 GBP 1,110.35	(5 pages)
04 Sep 2018	SH01	Statement of capital following an allotment of shares on 23 July 2018 GBP 1,060.56	(5 pages)
16 Aug 2018	RESOLUTIONS	Resolutions RES13 ‐ Auth to allot 23/07/2018 RES11 ‐ Resolution of removal of pre-emption rights	(2 pages)
13 Jun 2018	AD01	Registered office address changed from Equity House 4-6 School Road Tilehurst Reading Berkshire RG31 5AL United Kingdom to 12 Park Lane Tilehurst Reading RG31 5DL on 13 June 2018	(1 page)